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Abstract Receptors of the innate immune system are the first
line of defence against infection, being able to recognise and
initiate an inflammatory response to invading microorgan-
isms. The Toll-like (TLR), NOD-like (NLR), RIG-I-like
(RLR) and C-type lectin-like receptors (CLR) are four recep-
tor families that contribute to the recognition of a vast range of
species, including fungi. Many of these pattern recognition
receptors (PRRs) are able to initiate innate immunity and
polarise adaptive responses upon the recognition of fungal
cell wall components and other conserved molecular patterns,
including fungal nucleic acids. These receptors induce effec-
tive mechanisms of fungal clearance in normal hosts, but
medical interventions, immunosuppression or genetic predis-
position can lead to susceptibility to fungal infections. In this
review, we highlight the importance of PRRs in fungal infec-
tion, specifically CLRs, which are the major PRR involved.
We will describe specific PRRs in detail, the importance of
receptor collaboration in fungal recognition and clearance,
and describe how genetic aberrations in PRRs can contribute
to disease pathology.
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Fungi are usually efficiently cleared by an intact immune
system; however, during immunosuppression, susceptibil-
ity to fungi increases and infection can be associated
with high mortality rates [1]. Advances in medical
technologies such as chemotherapy or indwelling medi-
cal devices and the appearance of immunosuppressive
viruses such as HIV have led to a marked increase in
the incidence of invasive fungal infection in the last
several decades. Superficial infections in immunocompe-
tent patients are also prevalent, including fungal keratitis
and chronic skin diseases such as chromoblastomycosis
[2, 3]. Coupled with the lack of reliable and swift iden-
tification methods and limited treatment options, inci-
dence and morbidity due to fungal infections is currently
at an unacceptably high rate.
Pattern recognition receptors (PRR) are germline-encoded
receptors that recognise a variety of pathogen-associated mol-
ecules (pathogen-associated molecular patterns, PAMPs)
expressed by an invading microorganism. These receptors
induce downstream events designed to eliminate the pathogen
from the host, including phagocytosis, respiratory burst, and
cytokine and chemokine release. PRRs are best characterised
into one of four families: the Toll-like (TLR), NOD-like
(NLR), RIG-I-like (RLR) and C-type lectin-like receptors
(CLR), each of which differ in ligand recognition, signal
transduction and sub-cellular localisation. Most PRRs are
expressed on dendritic cells (DCs) and other myeloid cells
and are notable for initiating innate immune defences; how-
ever, PRR signalling can also direct the development of the
adaptive immune response by secreting cytokines which po-
larise CD4+ T cells (T-helper or Th cells) [4, 5]. For fungi,
Th1 and/or Th17 immunity is crucial for clearance of
infection [6, 7].
Our current knowledge demonstrates that CLRs are the
major receptor group for the recognition of fungi, while TLRs
and NLRs play ancillary roles. This review will assess the
current knowledge of selected PRRs in the pathogenesis of
fungal infection, in particular how defects in host PRR sig-
nalling and immune evasion tactics allow fungal pathogens to
thrive in the host.
This article is a contribution to the special issue on Immunopathology of
Fungal Diseases - Guest Editor: Jean-Paul Latge
A. Plato : S. E. Hardison :G. D. Brown (*)
Division of AppliedMedicine Immunity, Infection and Inflammation
Programme Room 4.20, Institute of Medical Sciences, Ashgrove
Road West University of Aberdeen, Aberdeen AB25 2ZD, UK
e-mail: gordon.brown@abdn.ac.uk
Semin Immunopathol (2015) 37:97–106
DOI 10.1007/s00281-014-0462-4
C-type lectin-like receptors
CLRs are transmembrane receptors expressed on, but not
restricted to, myeloid cells including macrophages and
DCs. CLRs can also be found on lymphocytes,
granulocytes, osteoclasts and epithelial cells [8–11].
CLRs are able to recognise a diverse range of ligands
via one or more C-type lectin-like domains (CTLD).
Evolutionary diversion of this domain from the carbohy-
drate recognition domain (CRD) of classical C-type
lectins has allowed them to recognise a range of mole-
cules including carbohydrates, lipids and proteins [11,
12]. CLRs recognise both endogenous and exogenous
ligands in the regulation of homeostasis and immunity,
utilising spleen tyrosine kinase (syk) as a primary signal
transduction molecule. Signalling commonly requires an
immunoreceptor tyrosine-based activation motif (ITAM)
or ITAM-like motif which is phosphorylated at tyro-
sine(s) within the consensus sequences (YxxI/L (6–
12)YxxI/L) and (YxxI/L) respectively. This motif can be
present within the signalling tail of the receptor itself or
an associated adapter chain such as FcRγ. As well as
cellular activation, many CLRs can perform inhibitory
roles by utilising an immunoreceptor tyrosine-based in-
hibitory motif (ITIM). Phosphorylation of the central
tyrosine within the consensus sequence (I/V/L/SxYxxI/
L/V) is involved in the recruitment of tyrosine phospha-
tases, exhibiting regulatory effects on other activation
pathways [13].
Current understanding is that ITAM motifs are phos-
phorylated by Src family kinase members, allowing the
recruitment and subsequent activation of syk. A large
network of proteins including phospholipase Cγ2
(PLCγ2), protein kinase Cδ (PKCδ), IκB kinase
(IKK) and the CARD9-Bcl10-MALT1 complex is
known to exist downstream of syk and upon activation,
these molecules regulate effects specific to each recep-
tor [14]. The CLRs Dectin-1, Dectin-2, CLEC-9A,
CLEC-2, and macrophage-inducible C-type lectin
(Mincle) signal via syk, but their biological roles can
differ greatly. Currently, CLEC-9A and CLEC-2 are
known to have important roles in cell damage detection
and platelet activation, respectively, whereas Dectin-1,
Dectin-2 and Mincle play major roles fungal and bac-
terial infections [14, 15]. On the other hand, ligand
binding to ITIM-containing receptors results in ITIM
phosphorylation and the association of SH2-domain-
containing protein tyrosine phosphatases including
(SHP)-1 and SHP-2, that are able to directly regulate
signalling downstream of ITAM motifs. CLRs such as
DCIR, MICL and MAH contain ITIM motifs [14];
however, in this review, we will focus on the activation
of CLRs related to fungal disease (Fig. 1).
Dectin-1/CARD9
Dectin-1 is a well-defined CLR that recognises β-1,3-glucans
present in the cell wall of Aspergillus, Candida and many
other fungal species [8, 16]. Dectin-1 contains a single CTLD
that is able to recognise fungal β-glucans and undefined
ligands on mycobacteria and T cells, although vimentin was
recently identified as possible endogenous Dectin-1 ligand
[17]. Upon ligand recognition, Dectin-1 signals through the
syk/CARD9 pathway via an ITAM-like motif. This motif is
present in the intracellular signalling tail of Dectin-1 and uses
a single phosphorylatable tyrosine residue to recruit syk to
dimerised Dectin-1 [18]. Through phosphorylation of phos-
pholipase C (PLC)γ2 and subsequent activation of protein
kinase C (PKC), syk activates the CARD9-Bcl10-MALT1
complex to induce canonical NF-κB activation. Syk can also
induce non-canonical NF-κB activation through NK-κB-
inducing kinase (NIK) [19–21]. These pathways induce cyto-
kine and chemokine production including TNF, IL-2, IL-10,
CXCL2 as well as IL-1β, IL-6 and IL-23, key cytokines in the
development of the antifungal Th17 response, as discussed
later [22–24]. Dectin-1 also induces phagocytosis, respiratory
burst and other antimicrobial effector mechanisms such as
activation of the NLRP3 inflammasome via ERK-induced
reactive oxygen species (ROS) production [14, 25]. The role
of the inflammasome in antifungal immunity will be discussed
in more detail later [26].
The importance of Dectin-1 in the control of fungal infec-
tions is highlighted by the susceptibility of Dectin-1-deficient
mice to infection with Candida albicans, Aspergillus
fumigatus and Pneumocystis carinii [22, 27, 28]. Interestingly,
the degree of susceptibility is strain-dependent in the case of
C. albicans [29]. Furthermore, Dectin-1 deficiency in humans
can lead to susceptibility to certain fungal infections including
chronic mucocutaneous candidiasis and recurrent
vulvovaginal candidiasis [30, 31]. Both of these infections
occur more frequently in patients containing a mutation in
Dectin-1 (Y238X) which results in the production of a trun-
cated protein. This truncation results in a loss of function and
as such, monocytes and macrophages from patients with this
polymorphism are deficient in cytokine secretion following
stimulation with particulate β-glucan or C. albicans [30]. The
Y238X polymorphism has also been shown in some studies to
be associated with susceptibility to invasive aspergillosis with
defective IFNγ, IL-10, IL-1β, IL-6 and IL-17 responses [32].
Recently, a polymorphism in Dectin-1 was identified that is
associated with severe, intractable forms of ulcerative co-
litis resulting from improper recognition of fungal gut
microbes [33].
Predisposition to fungal infections can also be seen in
CARD9-deficient humans. CARD9 deficiency has been stud-
ied in a family in which eight members were affected with a
mutation causing a premature stop codon (Q295X), resulting
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in a truncated protein [31]. Three of these individuals died
from invasive candida infections of the brain in early child-
hood, while four family members were affected by recurrent
mucocutaneous candidiasis.
Dectin-2/Mincle
The roles of Dectin-2 and Mincle in immunity are well-
characterised, and both recognise fungi. Unlike Dectin-1, the
CTLD of Dectin-2 is more like a classical CRD, containing
the short Glu-Pro-Asn (or EPN) motif that recognises man-
nose structures in a calcium-dependent manner. For both
Dectin-2 and Mincle, surface expression and signal transduc-
tion require an associated FcRγ signalling adapter that con-
tains an ITAM motif. The two tyrosines within the ITAM
consensus sequence are phosphorylated by Src family
kinases, allowing recruitment of syk to the activated re-
ceptor and signalling via the CARD9-Bcl10-MALT1
complex. Cytokine transcription is initiated via ERK,
p38 and MAP kinases [15, 34].
Dectin-2 has been shown to recognise C. albicans,
A. fumigatus, Saccharomyces cerevisiae, Cryptococcus
neoformans, Histoplasma capsulatum, Trichophyton rubrum,
Microsporum audouinii andMalassezia spp. Dectin-2−/− bone
marrow-derived dendritic cells (BMDC) are unable to induce
cytokine responses to C. albicans, including IL-1β, IL-6,
TNF, IL-12p40 and IL-10, and Dectin-2−/− mice are more
susceptible to C. albicans infection. Furthermore, Dectin-2−/
− mice are deficient in Th17 polarisation in response to
C. albicans, an effect dependent on the syk/CARD9 pathway
[35]. Activation of Dectin-2 on human DCs selectively acti-
vates the NF-κB subunit c-Rel via Malt1 activation. This is
unlike Dectin-1, where ligand recognition results in activation
of all NF-κB subunits [21, 34]. MALT1/c-Rel activation by
Dectin-1 and Dectin-2 was shown to be important for the
induction of a Th17 response [34–36]. Susceptibility to fungal
disease due to Dectin-2 polymorphisms has not yet been
described in humans.
While Mincle is primarily known for its role in
recognising mycobacteria, this CLR is also able to recog-
nise fungal species including Candida, Malassezia and
Fonsecaea species [1, 37]. Recognition of these fungi by
Mincle can lead to phagocytosis, fungal killing and in-
duction of TNF, IL-6, MIP-2 and KC in macrophages [15,
38, 39], and clearance of murine Fonsesaea pedrosoi
infection is dependent on Mincle [40]. The role of Mincle
in anti-Candida immunity is controversial, with contrast-
ing data on the importance of this receptor in vivo [38,
41]. Similarly to Dectin-2, there are no known human
polymorphisms in Mincle that lead to susceptibility to
fungi.
Fig. 1 Examples of activation
signals initiated by CLRs: both




of syk directly to phosphorylated
tyrosine residues results in
downstream activation of the
CARD9-Bcl10-Malt1 complex.
DC-SIGN contains no tyrosine-
based motifs but is able to induce
phosphorylation and acetylation
of NF-κB subunit p65 via the
assembly of signalosome. DC-
SIGN activation of p65 is Raf-1-
dependent
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DC-SIGN
Dendritic cell-specific intercellular adhesion molecule-3
grabbing non-integrin (DC-SIGN, murine homolog
SIGNR1) is a transmembrane CLR that contains a single
CRD that recognises carbohydrate-based ligands includ-
ing mannose and fucose structures. Unlike the other C-
type lectins already discussed, DC-SIGN does not have
tyrosine-based signalling motifs within its intracellular
tail, instead it contains di-leucine (LL) and tri-acidic
(EEE) motifs. Very little is known about the signal trans-
duction pathways utilised by DC-SIGN; however, it has
been shown that DC-SIGN can activate Raf-1, a serine/
threonine MAP kinase that is involved in the acetylation
the NF-κB subunit, p65. Interestingly, this acetylation
only takes place on p65 molecules that were previously
activated by TLRs. This acetylation enhances and pro-
longs transcription of the IL-10 gene, leading to an en-
hanced anti-inflammatory response [42]. Interactions of
CLRs and TLRs such as this are crucial to antifungal
immunity, and will be discussed in greater detail in fol-
lowing sections [14, 24, 42, 43].
The ability of DC-SIGN to recognise varied carbohy-
drate structures allows it to differentiate between diverse
organisms such as C. albicans , Mycobacterium
tuberculosis, HIV-1, or Helicobacter pylori, allowing a
tailored response to each through the formation of the
DC-SIGN signalosome (Fig. 2) . The DC-SIGN
signalosome is a complex required for the constitutive
association of DC-SIGN with Raf-1. This complex is
made up of the scaffold proteins LSP1, KSR1 and CNK,
and the association or dissociation of this complex allows
varying inflammatory responses depending on the ligand
associated. For example, IL-10, IL-12 and IL-6 expression
is observed upon mannose recognition. Here, recruitment
of LARG and RhoA to the signalosome results in activa-
tion of Ras and Raf-1 for the regulation of TLR4 path-
ways. On the other hand, fucose stimulation of DC-SIGN
results in the dissociation of this complex and the down-
regulation of IL-6 and IL-12 in an LSP-dependent man-
ner. [43]. Interestingly, DC-SIGN can also cooperate with
the mannose receptor (MR) to repress Dectin-1-dependent
Th17 development in human DCs upon stimulation with
either β-glucans or M. tuberculosis [44].
DC-SIGN is also able to recognise A. fumigatus, and
human polymorphisms in DC-SIGN cause increased suscep-
tibility to invasive pulmonary aspergillosis (IPA), a life-
threatening infection of respiratory tracts often seen in patients
with neutropenia or other immunosuppression [45, 46]. Sev-
eral single nucleotide polymorphisms (SNPs) were shown to
increase the risk of developing IPA by 2-fold in patients that
had undergone haematopoietic stem cell transplantation
(HSCT) or chemotherapy.
Mannose receptor
The MR is a CLR that recognises multiple fungi, bacteria and
viruses via eight extracellular CTLDs. Specifically, the CTLD
recognises terminal mannose and fucose-based structures as
well as N-acetyl glucosamine [24]. Unlike the other CLRs
discussed here, the MR extracellular domain can be cleaved
by a metalloproteinase to form soluble MR (sMR). MR shed-
ding was shown to be induced by Dectin-1 recognition of
zymosan, C. albicans, A. fumigatus and cell wall components
of S. cerevisiae. Interestingly, sMR is still able to recognise
pathogen and host molecules [47]. The MR is able to induce
ROS and cytokine production; however, as its signalling tail
lacks known motifs; it is thought that responses to C. albicans
involve collaboration with Dectin-1 and peroxisome
proliferator activated receptor γ (PPARγ) [48]. MR is known
to play a role in the development of Th17 responses to
C. albicans; however, MR knockouts are not susceptible to
C. albicans infection [49].
TOLL-like receptors
Although CLRs are considered to be the primary receptor
class for fungal recognition, members of the TLR family and
their interactions with CLRs are critical to antifungal immu-
nity. TLRs are considered to be the most well-defined of the
four families of PRRs. There are 13 members in mice, and
TLR1-10 are expressed in humans. All of these members are
transmembrane receptors expressed either at the cell surface,
in the case of TLR1, 2, 4, 5, 6 and 10, or on intracellular
membranes in the case of TLR3, 7, 8, 9. Transmembrane
TLRs recognise PAMPs present in cell walls and membranes,
for example, lipopolysaccharide (LPS) and peptidoglycan,
which are recognised by TLR4 and TLR2, respectively. Al-
ternatively, TLRs present on intracellular membranes recog-
nise fungal, bacterial and viral nucleic acids within an infected
cell. TLRs (with the exception of TLR3) are all able to signal
through MyD88, which has been shown to be crucial in the
clearance of infections. MyD88−/− mice have been shown to
be sensitive to fungal infections, including C. albicans and
A. fumigatus, and MyD88 is required for optimal Th1 re-
sponses to fungi in mice [50].
Individually, TLR2, 4, 7 and 9 have been shown to play
roles in C. albicans infections in mice. TLR4-defective (C3H/
HeJ) mice are more susceptible to disseminated candidiasis,
characterised by increased kidney fungal burdens and reduced
neutrophil recruitment [51]. Similarly, TLR2−/− mice are sus-
ceptible to systemic challenge withC. albicans. [52]. It should
be noted, however, that TLR recognition of different
C. albicans strains as well as other fungi is highly variable,
leading to some confusion in the literature [53]
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In humans, complete lack of TLR functionality, through
mutation of key downstream signalling adaptors such as
MyD88 does not predispose individuals to fungal infections
[54]. This demonstrates that TLRs are not the central PRRs
involved in antifungal immunity in humans. However, in
immunocompromised hosts, polymorphisms in the TLR
genes can result in a predisposition to fungal infections
[55–58]. For example, D299G polymorphism in TLR4 in-
creases susceptibility to chronic cavity pulmonary aspergillo-
sis (CCPA), a subacute cavity-forming aspergillosis. Interest-
ingly, TLR2 SNPs showed no susceptibility to CCPA but a
potentially protective role in allergic bronchopulmonary as-
pergillosis (ABPA), whereas patients suffering from ABPA
had significantly higher frequency of a TLR9 SNP (T-1237C)
compared to unaffected controls [58].
Collaboration between CLRs and TLRs
TLRs and CLRs are both required for antifungal responses,
and these pathways interact to induce optimal immunity de-
pendent on Syk/CARD9 and MyD88 signalling pathways [1,
59, 60]. For example, co-stimulation with both Dectin-1 and
TLR2 or TLR4 ligands leads to a synergistic increase in TNF,
IL-10 and IL-23 and a decrease in IL-12 production (Fig. 3)
[1, 60, 61]. SIGNR1, a murine homolog of DC-SIGN, also
collaborates with TLRs in the recognition of C. albicans.
Recent studies have demonstrated that SIGNR1 suppresses
the function of TLR2 by down-regulating TNF, IL-6, IL-
12p40 and FSL-1-mediated activation of NF-κB [62]. How-
ever, in collaboration with TLR2 and Dectin-1, SIGNR1-
expressing macrophages were shown to induce TNF produc-
tion [63]. These functions are not abolished by mutation of the
SIGN-R1 intracellular tail, suggesting no signalling role for
SIGN-R1; however, the overall mechanism is still unclear [63,
64]. It is hypothesised that this receptor aids binding of fungi
at the cell surface, or that it interacts with other receptors at the
site of microbe contact.
Modulating CLR and TLR collaboration has been utilised
therapeutically in the treatment of fungal infections, such as
for the clearance ofF. pedrosoi from infectedmice. F. pedrosoi
is the causative agent of the chronic skin disease
chromoblastomycosis, and is recognised by Mincle. Patients
with severe F. pedrosoi infection may have prolonged anti-
fungal treatment courses [65]; however, recent studies have
shown that application of topical TLR7 ligand, imiquimod,
results in rapid clearance of infection in mice as well as small
cohort of human patients [1, 37, 40]. Similar observations of
CLR and TLR collaboration were made for the reduction of
P. carinii lung burden in mice. Treatment with aerosolised
heat-killed E. coli was able to induce clearance of the infec-
tion, likely through Dectin-1 and TLR2 collaboration [66, 67].
Fig. 2 DC-SIGN pathogen
recognition determines
downstream TLR regulation.
Formation or disassembly of the
DC-SIGN signalosome is able to
tailor TLR signalling pathways
towards a more effective response
to each pathogen encountered.
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Recently, collaboration between different CLRs has also
been described. For example, Mincle and Macrophage C-type
lectin (MCL, also CLECSF8 or CLEC4D) form a receptor
complex with the signalling adaptor FcRγ to induce down-
stream signalling through syk/CARD9. Both receptors and
FcRγ were shown to be required for optimal phagocytosis
[68, 69]. Furthermore, Mincle activation was recently shown
to inhibit Dectin-1 induced proinflammatory responses [70].
Further investigation of multiple CLR interactions may an-
swer questions about other instances of modified ligand rec-
ognition during receptor complex formation.
NOD-like receptors
NLRs are cytoplasmic receptors that recognise PAMPs of
internalised microbial components. Currently, there are 23
known human NOD-like receptors that are broadly
categorised into two subfamilies: the NOD subfamily,
characterised by the presence of one or more CARD domain,
and the NOD leucine-rich repeat and pyrin domain-containing
protein (NLRP) subfamily characterised by the presence of a
pyrin domain. Notable members of the NOD subfamily in-
clude NOD1 and NOD2. These receptors are well studied, in
particular the role of NOD2 in Crohn’s disease; however, the
receptors of importance in antifungal immunity are those that
form an inflammasome complex. Inflammasomes are innate
immune complexes that cleave pro-IL-1β and pro-IL-18 into
their biologically active forms. Cleavage of pro-IL-1β/18 is
often considered the secondary signal to IL-1β/18 production,
the first signal being PAMP recognition and production of
pro-IL-1β/18 by NF-κB activation [26, 71]. NLRs capable for
forming inflammasomes include NLRP1, 2, 3, 6, 7 and
NLRC4 and 5 where, upon ligand activation, they associate
with ASC and caspase-1 to form the basis of the
inflammasome [72].
Although its ligand is yet to be defined, NLRP3 is a well-
studied inflammasome NLR and is known to contribute to
antifungal immunity [26, 71, 73]. Observations of NLRP3
revealed that it is essential in the control of mucosal and
disseminated C. albicans infections by the processing of
pro-IL-1β to IL-1β downstream of Dectin-1 and TLR2 [71].
Importantly, NLRP3 recognition of C. albicans requires the
fungus to be in a filamentous state, asC. albicans incapable of
forming hyphae do not induce this response [74]. Both cas-
pase-1−/− and ASC−/− mice were susceptible to C. albicans
infection compared to wild-type mice, likely due to increased
fungal burdens in both knockouts as well as tissue invasion in
the caspase-1−/− mice. Reduced IL-1 and IL-17 were found at
the site of infection as well as little neutrophil infiltration.
Fig. 3 Dectin-1 and Dectin-2
contribute to Tcell differentiation:
Dectin-1 and Dectin-2 are able to
induce Th17-polarising cytokine
secretion from DCs upon ligand
activation and subsequent syk/
CARD9 activation. As well as
this IL-17 production can be
directly induced by Dectin-1
activation from γδ T cells,
increasing anti-fungal activity
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BMDCs from these knockouts also showed defective produc-
tion of IL-1β and IL-18, cytokines responsible for Th17 and
Th1 polarisation, respectively, suggesting that the NLRP3
inflammasome can control T-helper responses to C. albicans
infection [75]. NLRP3 has also been shown to induce IL-1β
maturation in response to A. fumigatus hyphae and relies upon
Dectin-1 activation of Syk as well as ROS production and K+
efflux [73]. Furthermore, using bone marrow chimera studies,
NLRC4 has been demonstrated to be important for controlling
candida infection at mucosal sites [76].
Interestingly, the caspase-8 inflammasome is able to induce
IL-1β independently of NLRs in a manner directly through
Dectin-1 signalling. In contrast to the NLRP3 inflammasome,
caspase-8 and ASC are recruited directly to the CARD9-
Bcl10-MALT1 signalling complex, where IL-1β cleavage
takes place. This pathway also activates the non-canonical
NF-κB subunit c-Rel which induces transcription of the
IL1β gene, allowing an effective antifungal response through
rapid IL-1β production [77].
The TH17 response in antifungal immunity
Th17 cells are a subset of CD4+ T cells involved in protective
immunity to fungal infections, and these responses appear to
be primarily triggered through CLRs. Defects in Th17 defence
often result in recurring fungal infection and autoimmune
disease [24, 78, 79]. Differentiation and development of
Th17 cells requires TGF-β, IL-6 and IL-21 along with IL-23
for growth and increased Th17 response. Transcription factors
including signal transducer and activator of transcription 3
(STAT3), RAR-related orphan receptor (ROR)α and RORγt
are also required for Th17 development and maintenance [80,
81]. Th17 cells produce the cytokines IL-17A and F that bind
the IL-17 receptor and induce the secretion of proinflamma-
tory factors including IL-6, IL-8 and GM-CSF as well as the
chemokines CXCL1 and CCL20, which are involved in mac-
rophage and neutrophil recruitment [82]. This strong proin-
flammatory effect can be seen in stromal cells of almost all
tissues [83].
CLRs are critical to the development of Th17 cells during
infection. In particular, Dectin-1 is able to regulate differenti-
ation of CD4+ T cells into Th17 cells by inducing DC activa-
tion through recognition ofβ-glucan and cytokine production.
This is dependent on both syk/CARD9 and Raf-1 pathways
where Th17-promoting cytokines IL-1β, IL-6 and IL-23 are
increased and Th1-promoting cytokine IL-12 is decreased [60,
84]. Dectin-2 shows a similar cytokine profile upon recogni-
tion of C. albicans, and when blocked, IL-17 production from
Tcells was prevented, suggesting Dectin-2 plays a pivotal role
in Candida-specific Th17 responses [34, 35]. Dectin-1-
expressing T cell receptor gamma-delta (TCRγδ) T cells have
also been shown to induce production of IL-17 upon
stimulation with β-glucan and curdlan. These γδ T cells are
thought to be important during an early innate response, as
they are potent sources of IL-17. The innate response can be
further amplified in the presence of IL-23, increasing IL-17
production, T cell expansion and neutrophil recruitment [85,
86]. Additionally, IL-17 can stimulate epithelial cells to pro-
duce neutrophil-recruiting chemokines and antimicrobial pep-
tides such as β-defensin and the S100A proteins [87].
Evidence of a protective role for Th17 cells have been
shown for multiple murine studies; however, it is apparent
that uncontrolled Th17 inflammation is deleterious. A lack of
Th17 polarisation leads to increased susceptibility to fungal
infections. For example, IL-23p19−/− mice, which are Th17
impaired, lack effective clearance of P. carinii as well as
reduced CD4+ T cells in the lungs [88]. IL-17A receptor-
deficient mice are severely impaired for clearance of
C. albicans, and increased mortality is observed in a model
of systemic candidiasis. Alternatively, driving Th17 responses
during C. albicans infection reduces Th1 immunity and re-
sults in generalised neutrophilic inflammation which exacer-
bates disease [89]. Th17 differentiation in response to
C. albicans is initiated by Dectin-1 via the syk-CARD9 com-
plex, and is independent of TLR signalling. Recently, defi-
ciencies in neutrophil recruitment to sites of infection have
been observed in an oropharyngeal candidiasis (OPC) model
in IL-17AR−/− and IL-23−/−mice [90]. Neutrophils exhibit IL-
17 autocrine activity that induces innate responses such as
ROS production and increased fungal killing. These responses
are induced by IL-6 and IL-23, and were completely depen-
dent on RORγt, suggesting the importance of neutrophils in
Th17 responses [2]. Recently, IL-17 was shown to be impor-
tant for controlling the ability of NK cells to produce GM-
CSF, a cytokine required to promote neutrophil antifungal
activities and essential for the control of systemic Candida
infections [91]. In humans, polymorphisms in genes which
regulate Th17 differentiation, such as IL-17, IL-17RA, STAT1
or STAT3, result in susceptibility to mucocutaneous candidi-
asis, demonstrating the essential nature of this pathway in
antifungal defence [92–94].
Immune evasion
Fungi can utilise differential expression of PAMPs to evade
recognition by the immune system. Masking or modification
of cell wall components can prevent PRR recognition. β-1,3-
glucans are highly immunostimulatory and are often masked
by less immunogenic structures in the outer cell wall [95]. For
example, C. albicans is able to mask β-1,3-glucan under a
layer of mannoproteins, preventing recognition by Dectin-1.
Although mannoproteins themselves are immunostimulatory,
it appears that the lack of β-glucan exposure results in a
defective co-stimulatory response between Dectin-1 and
TLR2/4 [96]. Surface β-glucan exposure is increased at bud
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scar; however, it is masked by mannans in the hyphal form.
Growth in the hyphal form could be seen as an evasion tactic,
as Dectin-1 has a reduced affinity for hyphal C. albicans
compared to the yeast form [97, 98]. In contrast, Dectin-2
can also recognise C. albicans, but is thought to preferentially
bind the hyphal morphology [99].
Masking of immunostimulatory molecules is observed in
other species of pathogenic fungus. For example,
H. capsulatum, the causative agent of the pulmonary disease
histoplasmosis, employs α-1,3-glucans to cover the β-1,3-glu-
can underneath. In the presence of this α-glucan layer, TNF
production is suppressed, suggesting this is an effective mech-
anism in reducing proinflammatory responses [100]. Alterna-
tively, P. brasiliensis, a fungus known to cause the systemic
infection paracoccidioidomycosis, reduces PAMP surface ex-
pression by converting the cell wall glucan linkage from β-1,3
to α-1,3-glucans during its transition into pathogenic yeast
form. C. neoformans also evades immune surveillance by
masking its PAMPs under a thick layer of polysaccharides
known as the capsule. Control of the capsule’s structure allows
C. neoformans to survive extracellular stresses [101]. Acapsular
mutants of C. neoformans are avirulent, demonstrating the
efficacy of the capsule in preventing efficient clearance from
the host [102]. Interestingly, the capsule can also bind mannan-
binding lectin, preventing complement activation [103, 104].
Conclusions
PRRs are the first line of defence in antifungal immunity. Upon
recognition of surface-expressed PAMPs such as β-glucan and
α-mannan, CLRs initiate inflammatory innate responses that in
turn polarise a Th17 adaptive immune response which is gener-
ally beneficial to fungal control and clearance. When these
immune defences fail, such as in immunocompromised hosts,
opportunistic fungal pathogens are able to establish potentially
life-threatening infections. Our current understanding of receptor
partnering is developing, and future workmay shed light on how
cooperation between CLRs and TLRs collectively recognises
different microbes and shape the development of immunity. It is
clear that host-pathogen interactions are highly complex, and
understanding these mechanisms will be crucial in developing
effective treatments against fungal infections in the future.
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